A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 11, 2007

Primary Completion Date

May 31, 2011

Study Completion Date

February 7, 2018

Conditions
Advanced Breast CancerAdvanced Malignant Solid TumorsBreast Neoplasms
Interventions
DRUG

HKI-272

DRUG

Paclitaxel

Trial Locations (32)

0

UNIMED Medical Institute, Hong Kong

1000

Institut Jules Bordet Unite du Chimiotherapie, Brussels

2610

Oncologisch Centrum GZA - Location St Augustinus, Wilrijk

8500

AZ Groeninge Campus Maria's Voorzienigheid (MV), Kortrijk

9000

Universitair Ziekenhuis Gent, Ghent

10032

Columbia University Medical Center, New York

48912

Mid-Michigan Physicians-HOS Division, Lansing

49085

Oncology Care Associates, Saint Joseph

49102

City Multifield Clinical Hospital #4 Department of chemotherapy, Dnipropetrovs'k State Medical Academy, Chair of Oncology and Medical Radiology, Dnipropetrovsk

78229

CTRC at The University of Texas Health Science Center, San Antonio

79031

State Oncological Regional Treatment and Diagnostic Center Department of chemotherapy, Lviv

92037

Scripps, Clinic General, La Jolla

92093

Moores UC San Diego Cancer Center, La Jolla

92123

Sharp Memorial Hospital, San Diego

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

100032

Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Beijing

100071

The Hospital Affiliated Academy Military Medical Science, Chinese People's Liberation Army, Beijing

100853

Chinese People's Liberation Army General Hospital, Beijing

300060

Tianjin Cancer Hospital, Tianjin

300121

Tianjin Union Medicine Center Department of Oncology, Tianjin

302004

Birla Cancer Centre, S.M.S. Medical College & Hospital, Jaipur

400012

Tata Memorial Hospital, Mumbai

411001

Jehangir Clinical Development Centre, Jehangir Hospital Premises, Pune

411004

M.M.F. Joshi Hospital & Ratna Memorial Hospital, Pune

02118

Boston University Medical Center, Boston

M5G 2M9

Princess Margaret Hospital University Health Network, Toronto

Unknown

Department of Medicine, Queen Mary Hospital, Hong Kong

Department of Surgery Queen Mary Hospital, Hong Kong

31-826

Wojewodzki Szpital Specjalistyczny im. Ludwika Rydygiera, Oddzial Onkologii, Krakow

20-090

Oddzial Chemioterapii Centrum Onkologii Ziemii Lubelskiej, Lublin

120-752

Yonsei University Health System - Severance Hospital, Seoul

138-736

Asan Medical Center, Division of Oncology, Department of Internal Medicine, Seoul

All Listed Sponsors
lead

Puma Biotechnology, Inc.

INDUSTRY

NCT00445458 - A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer | Biotech Hunter | Biotech Hunter